140 related articles for article (PubMed ID: 21427028)
1. [Therapy-related acute myeloid leukemia: role of DNA repair].
Guièze R; Ravinet A; Hermet E; Maliki Y; de Botton S; Bay JO
Bull Cancer; 2011 Mar; 98(3):247-55. PubMed ID: 21427028
[TBL] [Abstract][Full Text] [Related]
2. Influence of DNA damage and repair upon the risk of treatment related leukemia.
Guillem V; Tormo M
Leuk Lymphoma; 2008 Feb; 49(2):204-17. PubMed ID: 18231906
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
4. The secondary leukemias: challenges and research directions.
Smith MA; McCaffrey RP; Karp JE
J Natl Cancer Inst; 1996 Apr; 88(7):407-18. PubMed ID: 8618232
[TBL] [Abstract][Full Text] [Related]
5. Human mismatch repair, drug-induced DNA damage, and secondary cancer.
Karran P; Offman J; Bignami M
Biochimie; 2003 Nov; 85(11):1149-60. PubMed ID: 14726020
[TBL] [Abstract][Full Text] [Related]
6. Incidence and susceptibility to therapy-related myeloid neoplasms.
Leone G; Fianchi L; Pagano L; Voso MT
Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.
Borthakur G; Estey AE
Curr Oncol Rep; 2007 Sep; 9(5):373-7. PubMed ID: 17706165
[TBL] [Abstract][Full Text] [Related]
8. Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.
Seedhouse C; Russell N
Br J Haematol; 2007 Jun; 137(6):513-29. PubMed ID: 17539774
[TBL] [Abstract][Full Text] [Related]
9. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
[No Abstract] [Full Text] [Related]
10. Successful treatment of both double minute of C-MYC and BCL-2 rearrangement containing large B-cell lymphoma with subsequent unfortunate development of therapy-related acute myeloid leukemia with t(3;3)(q26.2;q21).
Nguyen JC; Kubik MJ; Broome HE; Curtin PT; Dell'Aquila ML; Wang HY
Pathol Res Pract; 2015 Nov; 211(11):883-91. PubMed ID: 26300063
[TBL] [Abstract][Full Text] [Related]
11. The Role of DNA Repair Pathways in AML Chemosensitivity.
Pearsall EA; Lincz LF; Skelding KA
Curr Drug Targets; 2018; 19(10):1205-1219. PubMed ID: 29318968
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF
Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia.
Jawad M; Seedhouse CH; Russell N; Plumb M
Blood; 2006 Dec; 108(12):3916-8. PubMed ID: 16902145
[TBL] [Abstract][Full Text] [Related]
14. A case of acute promyelocytic leukemia presenting with a nonleukemic granulocytic sarcoma of the ovary, with subsequent development of acute myeloid leukemia associated with t(8;21).
Wang X; Liu H; Wu Z; Xu X; Chen X; Zhai Z; Sun Z
Leuk Res; 2009 Apr; 33(4):580-2. PubMed ID: 18804280
[No Abstract] [Full Text] [Related]
15. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
[TBL] [Abstract][Full Text] [Related]
16. Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
Owatari S; Otsuka M; Uozumi K; Takeshita T; Hanada S
Int J Hematol; 2007 Jan; 85(1):32-5. PubMed ID: 17261499
[TBL] [Abstract][Full Text] [Related]
17. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.
Pedersen-Bjergaard J; Rowley JD
Blood; 1994 May; 83(10):2780-6. PubMed ID: 8180374
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.
Boyd EM; Bench AJ; Vaghela KJ; Campbell GN; Chowdhury FB; Gudgin EJ; Scott MA; Erber WN
Leukemia; 2009 Jun; 23(6):1164-7. PubMed ID: 19158836
[No Abstract] [Full Text] [Related]
19. Molecular cytogenetics reveals complex karyotype in apparent t(8;13) therapy-related acute myeloid leukemia M2 after fibrosarcoma.
Soares-Ventura EM; Mkrtchyan H; de Jesus Marques-Salles T; Silva M; Santos N; de Araujo Silva Amaral B; Liehr T; Abdelhay E; Silva ML; Muniz MT
Leuk Res; 2011 May; 35(5):e27-9. PubMed ID: 21329977
[No Abstract] [Full Text] [Related]
20. [Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Miyata A; Deguchi S; Fujita M; Kikuchi T; Honda K
Rinsho Ketsueki; 1996 May; 37(5):448-51. PubMed ID: 8691593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
